Theratechnologies Profit margin
What is the Profit margin of Theratechnologies?
The Profit margin of Theratechnologies, Inc. is -29.31%
What is the definition of Profit margin?
Profit margin is a measure of profitability and is calculated by finding the net profit as a percentage of the revenue.
lfy (last fiscal year)
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Profit margin of companies in the Health Care sector on TSX compared to Theratechnologies
What does Theratechnologies do?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Companies with profit margin similar to Theratechnologies
- Cominar Real Estate Investment Trust has Profit margin of -29.42%
- iHeartMedia has Profit margin of -29.40%
- Orion Office REIT has Profit margin of -29.38%
- Baumot AG has Profit margin of -29.36%
- Delta Magnets has Profit margin of -29.34%
- Cellmid has Profit margin of -29.31%
- Theratechnologies has Profit margin of -29.31%
- Forgame has Profit margin of -29.28%
- Casa Systems Inc has Profit margin of -29.27%
- Kalray S.A has Profit margin of -29.26%
- Bossini International has Profit margin of -29.25%
- Renavotio Inc has Profit margin of -29.24%
- V.S. International has Profit margin of -29.20%